Resources

A physiological research team monitors endometrial histology and serum steroid hormone dynamics during a standardized 28-day menstrual cycle. On Day 21 of the cycle (the mid-luteal implantation window), an endometrial biopsy demonstrates a peak secretory endometrial thickness of 11.0 mm11.0\text{ mm}, supported by a steady-state progesterone production rate of 25.0 mg/day25.0\text{ mg/day} from the corpus luteum. In a parallel experimental cohort, administration of a high-affinity competitive progesterone receptor antagonist (RU-486 / mifepristone) at an oral dose of 200 mg200\text{ mg} occupies 80.0%80.0\% of nuclear progesterone receptors in endometrial stromal cells despite normal endogenous hormone levels. Calculate: (a) the remaining effective percentage of active progesterone-receptor signaling complexes, (b) identify whether the endometrium will maintain decidualization or undergo breakdown/menses under this receptor blockade, and (c) identify the hypothalamic-pituitary-ovarian axis response regarding LH and FSH secretion if the corpus luteum subsequently undergoes luteolysis on Day 26.

Answer and steps

Final answer

(a) Remaining active signaling complexes: 20.0%20.0\%; (b) Endometrial fate: Breakdown and premature shedding (menses) due to loss of sustained progesterone signaling; (c) Endocrine response: Decline in progesterone and estradiol triggers disinhibition (relief of negative feedback), resulting in increased pulsatile secretion of GnRH, FSH, and LH.

Steps

Part (a): Determining Remaining Active Signaling Complexes

  1. Receptor Occupancy Principle: In competitive receptor antagonism, the antagonist binds directly to the ligand-binding domain of the receptor, preventing endogenous progesterone from binding and forming transcriptionally active complexes.
  2. Calculation: Given that the antagonist occupies 80.0%80.0\% of the total available nuclear progesterone receptors: Fraction of active complexes=100.0%−80.0%=20.0%\text{Fraction of active complexes} = 100.0\% - 80.0\% = 20.0\% Therefore, the remaining functional signaling capacity is reduced to 20.0%20.0\%.

Part (b): Fate of the Endometrium Under Receptor Blockade

  1. Role of Progesterone in Decidualization: During the mid-luteal phase (around Day 21), high circulating progesterone promotes stromal cell decidualization, gland tortuosity, glycogen secretion, and vascularization via spiral arterioles, maintaining endometrial stability for embryo implantation.
  2. Effect of Mifepristone (RU-486): A sharp 80.0%80.0\% reduction in functional progesterone signaling mimics the hormonal withdrawal that normally initiates menstruation:

    • Decidual stromal integrity is compromised.
    • Local synthesis of prostaglandins (PGFX2α\ce{PGF_{2\alpha}}) increases, causing vasoconstriction and localized ischemia in spiral arterioles.
    • Matrix metalloproteinases are activated, breaking down the extracellular matrix.
  3. Conclusion: The endometrium cannot maintain decidualization and undergoes structural breakdown and premature shedding (menstruation).

Part (c): Hypothalamic-Pituitary-Ovarian Axis Response Post-Luteolysis

  1. Normal Negative Feedback in the Luteal Phase: During the luteal phase, elevated levels of progesterone and estradiol from the functional corpus luteum exert strong negative feedback on the hypothalamus and anterior pituitary gland, suppressing gonadotropin-releasing hormone (GnRH\text{GnRH}), luteinizing hormone (LH\text{LH}), and follicle-stimulating hormone (FSH\text{FSH}) secretion.
  2. Hormonal Changes During Luteolysis (Day 26): When the corpus luteum regresses into the corpus albicans, secretion of both progesterone and estrogen plummets.
  3. Feedback Release (Disinhibition): The withdrawal of circulating steroids removes the negative feedback inhibition (disinhibition) on the hypothalamus and anterior pituitary:

    • Hypothalamic GnRH\text{GnRH} pulse frequency and amplitude increase.
    • Anterior pituitary secretion of FSH\text{FSH} and LH\text{LH} rises, initiating the recruitment of a new follicular cohort for the subsequent menstrual cycle.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student assumes that high circulating progesterone can overcome competitive inhibition without receptor availability, incorrectly concluding the endometrium will be maintained.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    100.0%−80.0%=20.0%  ⟹  Remaining active signaling complexes=20.0%100.0\% - 80.0\% = 20.0\% \implies \text{Remaining active signaling complexes} = 20.0\%

  2. Step 2

    Endogenous progesterone level is normal at 25.0 mg/day  ⟹  25.0\text{ mg/day} \implies High hormone concentration compensates for receptor blockade   ⟹  \implies The endometrium will maintain decidualization

    Correct

    The endometrium cannot sustain decidualization with only 20.0%20.0\% functional signaling and will undergo ischemic breakdown and shedding (premature menses).

    Because the antagonist already occupies 80.0%80.0\% of the receptors at equilibrium, downstream progesterone-dependent transcription drops significantly. Endometrial decidualization requires sustained, high-level receptor signaling; reducing active complexes to 20.0%20.0\% mimics hormone withdrawal, triggering spiral arteriole constriction, matrix metalloproteinase activation, and endometrial breakdown.

  3. Step 3

    Luteolysis decreases progesterone and estradiol   ⟹  \implies Negative feedback on the pituitary is removed   ⟹  \implies LH and FSH secretion will increase

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly calculated the net percentage of available progesterone receptors under competitive blockade.

You correctly analyzed the endocrine feedback mechanism of the hypothalamic-pituitary-ovarian axis following luteolysis.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Receptor Occupancy vs. Tissue Response Misconception

none

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You assumed that normal endogenous hormone production can overcome competitive antagonism that is already established at 80.0%80.0\% receptor occupancy, overlooking that tissue maintenance depends on the absolute level of active receptor-effector signaling rather than circulating hormone concentration alone.

REASONING PATH
Your ACEpath teacher’s suggested approach
Evaluate Net Signal Transduction
  • Tissue response is dictated by the fraction of receptors actively occupied by agonists, not by circulating hormone concentration in isolation.

  • Check whether the remaining active fraction (20.0%20.0\%) meets the physiological threshold required to sustain the specialized tissue state.

Recognize Hormone Withdrawal Triggers
  • Blocking progesterone receptor signaling produces the same functional consequence as systemic progesterone withdrawal: arteriole spasm, ischemia, and shedding.

  • Treat substantial receptor blockade as a functional hormone withdrawal event that induces menstruation.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Establish that 80.0%80.0\% of nuclear progesterone receptors are occupied by the antagonist mifepristone, leaving only 20.0%20.0\% functional signaling capacity.

  2. Determine that decidual maintenance of the secretory endometrium requires sustained, robust progesterone-mediated gene transcription.

  3. Conclude that dropping to 20.0%20.0\% signaling simulates progesterone withdrawal, causing spiral artery collapse, extracellular matrix degradation, and menstrual shedding.

Final answer

(a) Remaining active signaling complexes: 20.0%20.0\%; (b) Endometrial breakdown and premature menses; (c) Removal of negative feedback causes an increase in LH and FSH secretion.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review how competitive antagonists shift dose-response curves and why fixed high receptor occupancy limits maximal tissue response.

  • Study the molecular cascade of luteal withdrawal that leads to spiral arteriole vasoconstriction and menstrual shedding.

OverviewACEpath Teacher's Diagnosis

02 The student confuses negative feedback with positive feedback during the luteal phase, concluding that declining progesterone causes LH and FSH to decrease.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Remaining fraction=100.0%−80.0%=20.0%\text{Remaining fraction} = 100.0\% - 80.0\% = 20.0\%

  2. Step 2

    Progesterone signaling is reduced to 20.0%  ⟹  Loss of trophic support causes spiral artery spasm and necrosis  ⟹  The endometrium will undergo breakdown/menses\text{Progesterone signaling is reduced to } 20.0\% \implies \text{Loss of trophic support causes spiral artery spasm and necrosis} \implies \text{The endometrium will undergo breakdown/menses}

  3. Step 3

    Luteolysis drops ovarian steroid output  ⟹  Loss of stimulation from the ovary reduces gonadotropin release  ⟹  LH and FSH secretion will decrease\text{Luteolysis drops ovarian steroid output} \implies \text{Loss of stimulation from the ovary reduces gonadotropin release} \implies \text{LH and FSH secretion will decrease}

    Correct

    Luteolysis drops ovarian steroid output  ⟹  Removal of negative feedback (disinhibition) on the hypothalamus and anterior pituitary  ⟹  LH and FSH secretion will increase\text{Luteolysis drops ovarian steroid output} \implies \text{Removal of negative feedback (disinhibition) on the hypothalamus and anterior pituitary} \implies \text{LH and FSH secretion will increase}

    High luteal levels of progesterone and estradiol exert negative feedback on the hypothalamus and anterior pituitary. When luteolysis lowers these steroid levels, it removes that brake (disinhibition), causing GnRH, LH, and FSH secretion to increase rather than decrease.

WHAT YOU DID WELL
Compliments from Your Teacher

You accurately calculated the remaining functional signaling capacity from the antagonist occupancy.

You correctly identified that the withdrawal of progesterone activity leads to endometrial ischemia, breakdown, and menses.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
HPO negative feedback misunderstanding

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You treated circulating luteal ovarian steroids as an activating or stimulatory signal for pituitary gonadotropin release, forgetting that progesterone and estradiol exert strong negative feedback during the luteal phase. Consequently, steroid withdrawal relieves inhibition (disinhibition) and causes gonadotropins to rise.

REASONING PATH
Your ACEpath teacher’s suggested approach
Steroid Feedback Polarity in the Luteal Phase
  • During the luteal phase, elevated progesterone and estradiol exert negative feedback on the hypothalamus (reducing GnRH) and anterior pituitary (reducing LH and FSH).

  • Always treat elevated luteal steroids as inhibitory brakes on gonadotropin secretion, not stimulatory drivers.

Disinhibition Principle
  • Removing an inhibitory influence (such as a drop in negative feedback steroids following luteolysis) causes target hormone secretion to rebound or increase.

  • When ovarian steroid output plunges due to corpus luteum regression, predict an increase in LH and FSH pulse amplitude and frequency.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify the baseline luteal feedback: Circulating progesterone and estradiol act on the hypothalamus and anterior pituitary to inhibit GnRH, LH, and FSH release.

  2. Evaluate the effect of luteolysis: Regression of the corpus luteum causes a steep decline in serum progesterone and estradiol levels.

  3. Determine the feedback consequence: The loss of these inhibitory steroids relieves negative feedback (disinhibition).

  4. State the hormonal outcome: Hypothalamic GnRH pulsatility accelerates, causing anterior pituitary secretion of LH and FSH to rise in order to recruit a new follicular cohort.

Final answer

LH and FSH secretion will increase due to the relief of steroid negative feedback (disinhibition) on the hypothalamus and anterior pituitary.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the dual feedback loops of the ovarian cycle, contrasting the rare mid-cycle estradiol positive feedback spike with the dominant negative feedback of the luteal phase.

  • Practice tracing hormonal cascades by explicitly labeling every arrow as either stimulatory (++) or inhibitory (−-) before deciding the net direction of change.

  • Solve targeted endocrine questions where an endocrine gland undergoes hypofunction or ablation to reinforce disinhibition of trophic hormones.

Lock it in

Similar question

01

A patient taking a selective estrogen receptor downregulator (SERD) experiences a 75%75\% reduction in active nuclear estrogen receptors in breast tissue, while serum estradiol remains at premenopausal levels (150 pg/mL150\text{ pg/mL}). Predict whether estrogen-dependent gene transcription in this tissue will increase, remain constant, or decrease, and state the governing physiological principle.

Answer

Decrease. Gene transcription depends on the absolute concentration of functional ligand-receptor complexes; reducing available receptor density by 75%75\% blunts downstream transcription despite normal circulating estradiol.

02

During the mid-luteal phase, an experimental animal is administered an infusion of a progesterone receptor antagonist that reduces active PR transcription complexes by 85%85\%. Describe two specific downstream biochemical or vascular events in the endometrial stroma that result from this receptor blockade.

Answer
  1. Increased local synthesis of prostaglandin PGFX2α\ce{PGF_{2\alpha}}, causing vasoconstriction and ischemia of endometrial spiral arterioles; 2. Activation of matrix metalloproteinases (MMPs), leading to extracellular matrix degradation and tissue breakdown.
03

A clinical trial evaluates two competitive antagonists targeting Receptor X on vascular smooth muscle. Antagonist A achieves 50%50\% receptor occupancy at steady state, while Antagonist B achieves 90%90\% occupancy. If maintaining arterial tone requires at least 30%30\% active receptor signaling, determine the fate of tone under each antagonist given normal baseline agonist levels.

Answer

Under Antagonist A, 50%50\% of receptors remain active (100%−50%=50%≥30%100\% - 50\% = 50\% \ge 30\%), so arterial tone is maintained. Under Antagonist B, only 10%10\% of receptors remain active (100%−90%=10%<30%100\% - 90\% = 10\% < 30\%), so arterial tone is lost (vasodilation occurs).

Loading workspace…